Share of Cost, Researchers find potential target for drug to treat allergic asthma
Tuesday, Jul. 29th 2014 8:00 AM
An enzyme that helps maintain immune system function by “throwing away” a specific protein has a vital role in controlling symptoms of allergic asthma, new research in mice suggests.The finding suggests that this enzyme, called Cbl-b, could be a target for drugs used to treat allergic asthma and other autoimmune disorders.
Related posts:
- Antibiotics Disturb Normal Gut Bacteria, Increase Severity Of Allergic Asthma Widely used antibiotics may increase incidence and severity of allergic asthma in early life, according to a University of British Columbia study. The study, published in the journal EMBO reports, shows that certain antibiotics that affect intestinal bacteria also had a profound impact on allergic asthma....
- A Vaccination For Allergic Asthma That Works Using Intramuscular Injection A Vaccination For Allergic Asthma That Works Using Intramuscular Injection...
- Share of Cost, New Regulator Identified In Allergic Diseases Share of Cost, New Regulator Identified In Allergic Diseases...
- Share of Cost, Vitamin D May Help Treat Asthma Share of Cost, Vitamin D May Help Treat Asthma...
- Asthma UK Comment On: Drug Side Effect Linked With Increased Health Risks For Over 65s You may have seen some stories in the media today about a study into the risks of elderly people taking combinations of common medicines, some of which are used to treat asthma and allergies. Cher Piddock, Lead Asthma Nurse at Asthma UK, says: ‘This interesting study highlights the possible risks of combining several common medicines […]...
- Share of Cost, Fresh Funding Gives Hope To A New Generation Of Asthma And Allergy Treatment Share of Cost, Fresh Funding Gives Hope To A New Generation Of Asthma And Allergy Treatment...
- Share of Cost, Medi-Cal, Link Between Acetaminophen Use In Adolescents And Doubled Risk Of Asthma New evidence linking the use of acetaminophen to development of asthma and eczema suggests that even monthly use of the drug in adolescents may more than double risk of asthma in adolescents compared to those who used none at all; yearly use was associated with a 50 percent increase in the risk of asthma....
- Share of Cost, Children Who Develop Asthma Have Lung Function Deficits As Neonates Share of Cost, Children Who Develop Asthma Have Lung Function Deficits As Neonates...
- Share of Cost, Study Shows Promise For New Drug To Treat Fragile X The first drug to treat the underlying disorder instead of the symptoms of Fragile X, the most common cause of inherited intellectual disability, shows some promise according to a new study published in the January issue of Science Translational Medicine. Researchers from Rush University Medical Center helped design the study and are now participating in […]...
- Share of Cost, Protein Linked To Hunger Also Implicated In Alcoholism Share of Cost, Protein Linked To Hunger Also Implicated In Alcoholism...
- Share of Cost, Early Exposure To Germs Is A Good Thing Share of Cost, Early Exposure To Germs Is A Good Thing...
- Share of Cost, Researchers Discover Master Regulator That Drives Majority Of Lymphoma New Findings Show Inhibiting Powerful Protein with New Agents May Supply Broad Benefit for Lymphoma Patients A soon-to-be-tested class of drug inhibitors were predicted to help a limited number of patients with B-cell lymphomas with mutations affecting the EZH2 protein. However, a research team, led by investigators at Weill Cornell Medical College, now report that […]...
- Share of Cost, Childhood Exposure To Germs May Help Immunity Share of Cost, Childhood Exposure To Germs May Help Immunity...
- Employing Bronchoscopy To Guide Effective Treatment For Refractory Asthma Employing Bronchoscopy To Guide Effective Treatment For Refractory Asthma...
- Researchers Develop Mouse Model To Help Find How A Gene Mutation Leads To Autism Researchers Develop Mouse Model To Help Find How A Gene Mutation Leads To Autism...
Posted on Tuesday, Jul. 29th 2014 8:00 AM | by Share of Cost | in Share of Cost | No Comments »